Musculoskeletal Disorders

Zoledronic acid, bisphosphonates, IFN-alpha and denosumab appear to prevent fractures and increase BMD in SM patients with osteoporosis.

After years of living with undiagnosed ISM and osteoporosis, I often wonder how different my life may have been, had I been diagnosed sooner.

A case of patient with osteoporosis and systemic mastocytosis (SM) has highlighted the treatments available and the need for more data.